Weekly Roundup: May 18, 2019
May 18, 2019•7 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
This week, the team discuss the deal between UK's National Health Service and Biogen prompting the successful reimbursement of Biogen’s Spinraza as a treatment for spinal muscular atrophy and Solid Biosciences’ clinical update on its Duchenne Muscular Dystrophy gene therapy product SGT-001.
Presenter: Aparna Krishnan
Contributor: Max Rex
Producer: Aparna Krishnan
For the best experience, listen in Metacast app for iOS or Android